Agenus | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Celldex Therapeutics USD 693.76M 53.4M 2025-03
CSL USD 11.31B 540M 2024-12
Dynavax Technologies USD 815.97M 32.97M 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Incyte USD 3.23B 7.24M 2025-03
J&J USD 71.55B 15.66B 2025-03
Jiangsu Hengrui CNY 35.97B 654.84M 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Merck EUR 12.41B 1.04B 2025-03
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Veracyte USD 383.15M 10.88M 2025-03



Agenus Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.